FDA Inspection 1261007 — Nostrum Laboratories, Inc.

Nostrum Laboratories, Inc. — FEI 1518957

The FDA completed an inspection of Nostrum Laboratories, Inc. on Mar 13, 2025 in Bryan, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bryan, OH (United States)

Citations

IDCFRDescription
192021 CFR 211.166(a)(3)Valid stability test methods
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.